Evidence map›Paper›PMID 29353373›Full record

ArticleNeurochemical research2019

Disturbance of Metabotropic Glutamate Receptor-Mediated Long-Term Depression (mGlu-LTD) of Excitatory Synaptic Transmission in the Rat Hippocampus After Prenatal Immune Challenge.

Mélanie Cavalier, Azza Ben Sedrine, Lea Thevenet, Nadine Crouzin, Janique Guiramand, Marie-Céleste de Jésus Ferreira, Catherine Cohen-Solal, Gérard Barbanel, Michel Vignes

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Mélanie CavalierUMR5247 Institut des Biomolécules Max Mousseron - University of Montpellier-CNRS-ENSCM, Team 'Pharmacochemistry of Synaptic transmission and Neuroprotection', University of Montpellier-Sciences Faculty, Place E Bataillon, 34095, Montpellier Cedex 05, France.
Azza Ben SedrineUMR5247 Institut des Biomolécules Max Mousseron - University of Montpellier-CNRS-ENSCM, Team 'Pharmacochemistry of Synaptic transmission and Neuroprotection', University of Montpellier-Sciences Faculty, Place E Bataillon, 34095, Montpellier Cedex 05, France.
Lea ThevenetUMR5247 Institut des Biomolécules Max Mousseron - University of Montpellier-CNRS-ENSCM, Team 'Pharmacochemistry of Synaptic transmission and Neuroprotection', University of Montpellier-Sciences Faculty, Place E Bataillon, 34095, Montpellier Cedex 05, France.
Nadine CrouzinUMR5247 Institut des Biomolécules Max Mousseron - University of Montpellier-CNRS-ENSCM, Team 'Pharmacochemistry of Synaptic transmission and Neuroprotection', University of Montpellier-Sciences Faculty, Place E Bataillon, 34095, Montpellier Cedex 05, France.
Janique GuiramandUMR5247 Institut des Biomolécules Max Mousseron - University of Montpellier-CNRS-ENSCM, Team 'Pharmacochemistry of Synaptic transmission and Neuroprotection', University of Montpellier-Sciences Faculty, Place E Bataillon, 34095, Montpellier Cedex 05, France.
Marie-Céleste de Jésus FerreiraUMR5247 Institut des Biomolécules Max Mousseron - University of Montpellier-CNRS-ENSCM, Team 'Pharmacochemistry of Synaptic transmission and Neuroprotection', University of Montpellier-Sciences Faculty, Place E Bataillon, 34095, Montpellier Cedex 05, France.
Catherine Cohen-SolalUMR5247 Institut des Biomolécules Max Mousseron - University of Montpellier-CNRS-ENSCM, Team 'Pharmacochemistry of Synaptic transmission and Neuroprotection', University of Montpellier-Sciences Faculty, Place E Bataillon, 34095, Montpellier Cedex 05, France.
Gérard BarbanelUMR5247 Institut des Biomolécules Max Mousseron - University of Montpellier-CNRS-ENSCM, Team 'Pharmacochemistry of Synaptic transmission and Neuroprotection', University of Montpellier-Sciences Faculty, Place E Bataillon, 34095, Montpellier Cedex 05, France.
Michel VignesUMR5247 Institut des Biomolécules Max Mousseron - University of Montpellier-CNRS-ENSCM, Team 'Pharmacochemistry of Synaptic transmission and Neuroprotection', University of Montpellier-Sciences Faculty, Place E Bataillon, 34095, Montpellier Cedex 05, France. michel.vignes@umontpellier.fr.
Centre National de la Recherche Scientifique · FRUniversité de Montpellier · FRÉcole Nationale Supérieure de Chimie de Montpellier · FRInstitut des Biomolécules Max Mousseron · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Maternal immune challenge has proved to induce moderate to severe behavioral disabilities in the offspring. Cognitive/behavioral deficits are supported by changes in synaptic plasticity in different brain areas. We have reported previously that prenatal exposure to bacterial LPS could induce inhibition of hippocampal long-term potentiation (LTP) in the CA1 area of the juvenile/adult male offspring associated with spatial learning inabilities. Nevertheless, deficits in plasticity could be observed at earlier stages as shown by the early loss of long-term depression (LTD) in immature animals. Moreover, aberrant forms of plasticity were also evidenced such as the transient occurrence of LTP instead of LTD in 15-25 day-old animals. This switch from LTD to LTP seemed to involve the activation of metabotropic glutamate receptor subtype 1 and 5 (mGlu1/5). We have thus investigated here whether the long-term depression elicited by the direct activation of these receptors (mGlu-LTD) with a selective agonist was also disturbed after prenatal stress. We find that in prenatally stressed rats, mGlu1/5 stimulation elicits long-term potentiation (mGlu-LTP) independently of N-methyl-D-aspartate receptors. Both mGlu5 and mGlu1 receptors are involved in this switch of plasticity. Moreover, this mGlu-LTP is still observed at later developmental stages than previously reported, i.e. after 25 day-old. In addition, increasing synaptic GABA with tiagabine tends to inhibit mGlu-LTP occurrence. By contrast, long-term depression induced with the activation of CB1 cannabinoid receptor is unaffected by prenatal stress. Therefore, prenatal stress drastically alters mGlu1/5-associated plasticity throughout development. MGlu-mediated plasticity is an interesting parameter to probe the long-lasting deficits reported in this model.

Indexed as

AnimalsDepressionExcitatory Amino Acid AntagonistsFemaleHippocampusLong-Term PotentiationNeuronal PlasticityRats, Sprague-DawleyReceptors, Metabotropic GlutamateReceptors, N-Methyl-D-AspartateSynaptic TransmissionExcitatory Amino Acid AntagonistsReceptors, Metabotropic GlutamateReceptors, N-Methyl-D-AspartateDihydroxyphenylglycineHippocampusLTDLTPmGlu1/5Prenatal stressSynaptic plasticity

Identifiers

PMID29353373
OpenAlexW2789721586

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.